New York State Common Retirement Fund’s Tonix Pharmaceuticals TNXP Stock Holding History

New York State Common Retirement Fund’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37K	Hold	2,900	–	–	﹤0.01%	3056
2026 Q1	$39.9K	Hold	2,900	–	–	﹤0.01%	2884
2025 Q4	$45.3K	Hold	2,900	–	–	﹤0.01%	2939
2025 Q3	$70.1K	Hold	2,900	–	–	﹤0.01%	2834
2025 Q2	$104K	Buy	+2,900	New	+$76K	﹤0.01%	2581
2024 Q4	–	Hold	0	–	–	–	3189
2024 Q3	–	Hold	0	–	–	–	3332
2023 Q2	–	Hold	0	–	-$1	–	3457
2023 Q1	–	Hold	0	–	–	–	3212
2022 Q4	–	Hold	0	–	–	–	3256
2022 Q3	–	Hold	0	–	–	–	3444
2022 Q2	–	Hold	0	–	–	–	3541
2022 Q1	–	Hold	0	–	–	–	3198
2021 Q4	–	Hold	0	–	–	–	3168
2021 Q3	–	Hold	0	–	–	–	3104
2021 Q2	–	Hold	0	–	–	–	2830

Other funds holding TNXP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CNBT

Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

New York State Common Retirement Fund's TNXP Position: Q2 2026 in Review

New York State Common Retirement Fund held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 2,900 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

New York State Common Retirement Fund first reported a position in TNXP in Q2 2025 and has held it in 5 quarters since. The position peaked at $104K in Q2 2025. 20 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

New York State Common Retirement Fund held 2,900 shares of Tonix Pharmaceuticals worth $37K as of Q2 2026.
New York State Common Retirement Fund left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3056 holding.
New York State Common Retirement Fund first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
New York State Common Retirement Fund's Tonix Pharmaceuticals position peaked at $104K in Q2 2025.
20 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.